Donbass Pharma Hub - Page 2

TNF Inhibitors and Cancer Risk: What You Really Need to Know

TNF inhibitors help control autoimmune diseases but raise cancer risk concerns. Learn what the latest data really says about skin cancer, lymphoma, and long-term safety-and how to make smart decisions with your doctor.

Jan 30 2026

Lithium and NSAIDs: Understanding the Deadly Nephrotoxicity Risk

Lithium and NSAIDs can cause dangerous kidney damage and life-threatening toxicity. Learn why this interaction is so risky, which painkillers are safer, and how to protect yourself if you're on lithium.

Jan 29 2026

Healthcare System Savings: How Generic Drugs Cut Billions in U.S. Drug Spending

Generic drugs saved $482 billion in U.S. healthcare spending in 2024, making up 90% of prescriptions but only 12% of costs. Biosimilars are the next frontier, with potential to save hundreds of billions more-if barriers to entry are removed.

Jan 28 2026

Generic Drug Interactions: Best Digital Consultation Tools for 2026

Discover the best digital tools to check generic drug interactions in 2026. Learn how Epocrates, Micromedex, and DDInter help prevent dangerous medication conflicts with real-world insights and expert data.

Jan 24 2026

Chemotherapy: How Cytotoxic Drugs Work and Common Side Effects

Chemotherapy uses cytotoxic drugs to kill rapidly dividing cancer cells. Learn how these drugs work, common side effects like fatigue and neuropathy, and how modern care improves tolerance and outcomes.

Jan 23 2026

Medicaid Generic Coverage: State-by-State Variations and Requirements

Medicaid generic drug coverage varies by state, with differences in formularies, copays, prior authorization, and substitution rules. Learn how each state manages generic medications and what you need to know to avoid coverage gaps.

Jan 21 2026

Alcohol and Medication Interactions: What Patients Need to Know

Alcohol can dangerously interact with many common medications, increasing side effects or causing life-threatening reactions. Learn which drugs are risky, what to do if you’ve already mixed them, and how to stay safe.

Jan 20 2026

Reducing Side Effects from Multiple Medications in Frail Older Adults

Frailty and polypharmacy create a dangerous cycle in older adults, increasing falls, hospitalizations, and side effects. Learn how deprescribing, pharmacist-led reviews, and the 4Ms Framework can reduce medication burden and improve quality of life.

Jan 19 2026

When Pharmacists Should Flag Problematic Generic Medications

Pharmacists play a critical role in spotting problematic generics that can harm patients despite FDA approval. Learn when and how to flag unsafe substitutions, especially with narrow therapeutic index drugs.

Jan 18 2026

Medicare Part D Economics: How Programs Use Generics to Cut Costs

Medicare Part D saves billions by prioritizing generic drugs through tiered formularies, low copays, and caps on out-of-pocket spending. Learn how the system works-and how to use it to cut your prescription costs.

Jan 17 2026

Asian Generic Markets: India, China, and Emerging Economies Explained

India and China dominate the global generic drug market, supplying affordable medicines worldwide. India leads in volume and speed, while China controls raw ingredients and is moving into high-value biologics. Emerging economies like Vietnam and Cambodia are carving out niche roles in this complex supply chain.

Jan 16 2026

Decongestants and Blood Pressure Medications: What You Need to Know About the Risks

Decongestants like pseudoephedrine and phenylephrine can raise blood pressure and interfere with heart medications. Learn which OTC cold remedies are risky for hypertensive patients and what safer alternatives exist.

Jan 15 2026